8-K: Aveanna Healthcare Secures $275 Million Receivables Financing Extension to Boost Liquidity

Aveanna Healthcare Holdings Inc. announced a seventh amendment to its Receivables Financing Agreement, increasing the available facility limit to $275 million and extending its scheduled termination date to June 25, 2028.

Summary

• Aveanna Healthcare Holdings Inc. (AVAH) has entered into a Seventh Amendment to its Receivables Financing Agreement, effective June 25, 2025.
• The amendment significantly increases the maximum amount available under the facility to $275.0 million, subject to maintaining certain borrowing base requirements.
• The scheduled termination date of the Receivables Financing Agreement has been extended by three years, from its previous term, to June 25, 2028.
• The Loan Parties involved are Aveanna Healthcare LLC and Aveanna SPV I, LLC, both wholly-owned subsidiaries of Aveanna Healthcare Holdings Inc.
• PNC Bank, National Association, continues its role as the Administrative Agent and a Lender, with PNC Capital Markets LLC acting as the Structuring Agent for the facility.

Sentiment

Score: 8

Explanation: The amendment significantly improves the company's liquidity and extends its debt maturity profile, which are strong positive indicators for financial stability and operational flexibility. While it's a debt facility, securing and expanding such a facility is a positive sign of lender confidence and access to capital.

Positives

• Increased liquidity and capital availability for Aveanna Healthcare Holdings Inc. through an expanded Receivables Financing Agreement, with the maximum amount rising to $275.0 million.
• Extension of the scheduled termination date of the financing facility by three years, providing longer-term financial stability and predictability until June 25, 2028.
• Continued access to a crucial working capital facility, which is vital for managing cash flow in the healthcare services industry.

Negatives

• The financing is subject to maintaining certain borrowing base requirements, which could limit actual availability if receivables quality or concentration thresholds are not met.
• The agreement includes various covenants and conditions, the breach of which could trigger an Event of Default, potentially leading to accelerated repayment obligations.

Risks

• Borrowing Base Requirements: The maximum available amount is subject to maintaining specific borrowing base requirements, meaning the full $275.0 million may not always be accessible if the quality or quantity of eligible receivables declines.
• Default Ratios: An average Default Ratio exceeding 7.0% over three consecutive fiscal months could trigger an Event of Default.
• Delinquency Ratios: An average Delinquency Ratio exceeding 25.0% (or 22.5% after June 2025) over three consecutive fiscal months could trigger an Event of Default.
• Dilution Ratios: An average Dilution Ratio exceeding 5.5% over three consecutive fiscal months could trigger an Event of Default.
• Days Sales Outstanding (DSO): DSO exceeding 55 days could trigger an Event of Default.
• Change in Control: A change in control of Aveanna Healthcare Holdings Inc. or its key subsidiaries could trigger an Event of Default.
• Material Indebtedness Defaults: Defaults on other material indebtedness of Aveanna or its restricted subsidiaries could trigger an Event of Default under this facility.
• ERISA Matters: Various ERISA-related events, such as a Pension Plan being at-risk, non-compliance, or withdrawal liability, could lead to an Event of Default.
• Material Adverse Effect: A material adverse effect on the business, operations, property, or financial condition of Aveanna, its Servicer, or Originators could trigger an Event of Default.
• Corporate Structure and Tax Status: Failure to maintain the Borrower's status as a special purpose entity, a disregarded entity for tax purposes, or compliance with tax laws could lead to an Event of Default.
• Legal and Regulatory Compliance: Non-compliance with applicable laws, including healthcare laws (e.g., Anti-Kickback Statute, HIPAA) and anti-terrorism/anti-corruption laws, could result in a Material Adverse Effect or directly trigger an Event of Default.

Future Outlook

The extension of the Receivables Financing Agreement until June 25, 2028, provides Aveanna Healthcare Holdings Inc. with a stable and extended period of access to significant working capital, supporting its ongoing operations and strategic initiatives.

Industry Context

The healthcare services industry, particularly those involved in home healthcare like Aveanna, often faces extended payment cycles due to reliance on government programs (Medicare, Medicaid, TRICARE) and private insurers. Receivables financing facilities are a common and critical tool for companies in this sector to manage working capital, bridge payment gaps, and ensure operational liquidity. The increase in the facility limit and extension of the term indicate a continued need for robust liquidity management and potentially support for growth initiatives or ongoing operational demands within this payment environment.

Related Party Transactions

• The Receivables Financing Agreement involves transactions between Aveanna Healthcare Holdings Inc. and its wholly-owned subsidiaries, Aveanna Healthcare LLC and Aveanna SPV I, LLC, which are considered related parties.
• The agreement details the flow of receivables and collections between these entities, including the transfer of receivables from Originators to Transferor (Aveanna) and then to the Borrower (Aveanna SPV I, LLC).

Stakeholder Impact

• Shareholders: Positive impact due to enhanced financial stability, improved liquidity, and reduced refinancing risk, which can support business operations and potential growth.
• Employees: Positive impact through increased business stability and continuity, potentially safeguarding employment.
• Customers: Positive impact as stable financing ensures the company can continue providing services without disruption.
• Suppliers: Positive impact as improved liquidity enhances the company's ability to meet its payment obligations to suppliers.
• Creditors: Positive impact as the extension of the facility and increased limit demonstrate continued access to capital, potentially improving the company's overall creditworthiness.

Next Steps

• Aveanna Healthcare Holdings Inc. will continue to operate under the terms of the amended Receivables Financing Agreement.
• The company will need to ensure ongoing compliance with all covenants, including borrowing base requirements, default ratios, and other financial and operational stipulations.
• Regular reporting, including Information Packages and Interim Reports, will continue to be provided to the Administrative Agent and Lenders.

Key Dates

Recommendation

Keywords

Aveanna Healthcare Holdings Inc., AVAH, Receivables Financing Agreement, SEC filing, 8-K, liquidity, credit facility, working capital, healthcare services, financing extension, PNC Bank, corporate finance, debt facility, asset-backed financing